Mayo Clinic Center for Innovation

ApolloMed and Wider Circle Enter Strategic Partnership to Elevate the Delivery of Patient-Centered Care for High-Need Community Members

Retrieved on: 
Tuesday, November 7, 2023

This program will leverage Wider Circle’s unique group-based engagement model and ApolloMed’s well-established comprehensive care management offering to elevate how social programs and clinical services are delivered – together – in the communities they collectively serve.

Key Points: 
  • This program will leverage Wider Circle’s unique group-based engagement model and ApolloMed’s well-established comprehensive care management offering to elevate how social programs and clinical services are delivered – together – in the communities they collectively serve.
  • “An interdisciplinary and coordinated approach to patient-centered care is critical in delivering whole person-centered care to members, especially for those with the most complex medical and social needs,” said Brandon Sim, Co-CEO of ApolloMed.
  • ApolloMed is focused on coordinating care for community members and empowering care providers with the technology and infrastructure they need to effectively deliver high-quality care to all.
  • ApolloMed continues to pair its significant experience with members with complex clinical care needs with its proprietary care management platform, evidence-based protocols, and clinical care delivery network to help deliver the best possible outcomes for these individuals.

Enovix Corporation Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Wednesday, October 11, 2023

​LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Enovix Corporation ("Enovix" or the "Company") (NASDAQ: ENVX) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Enovix stock. Enovix investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • ​LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Enovix Corporation ("Enovix" or the "Company") (NASDAQ: ENVX ) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Enovix stock.
  • Enovix investors are encouraged to contact the firm to discuss their legal rights.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

Launch of RICOH Remote Patient Monitoring Enablement Designed to Help Ease Healthcare Staffing Challenges Amid Unprecedented Industry Burnout Crisis

Retrieved on: 
Wednesday, October 4, 2023

EXTON, Pa., Oct. 4, 2023 /PRNewswire/ --  Ricoh USA, Inc. today announces the launch of RICOH Remote Patient Monitoring (RPM) Enablement, the newest end-to-end managed services offering for health systems that is designed to help fuel more efficient and sustainable RPM workflows that can lead to improved patient and care delivery team experiences. RICOH RPM Enablement comes at a time when health systems are grappling with a simultaneous monumental shift to virtual care delivery and an unprecedented shortage of healthcare workers. This care worker shortage has reached a nationwide crisis level where there aren't nearly enough healthcare staff to fill vital RPM management roles, leading to alarming care gaps impacting the most vulnerable patient populations. RICOH RPM Enablement is designed to help health systems close this gap and to help lead to improved patient experiences by integrating into existing virtual care programs to support the deployment of remote patient monitoring system devices, inventory tracking, logistics, and device returns.

Key Points: 
  • today announces the launch of RICOH Remote Patient Monitoring (RPM) Enablement, the newest end-to-end managed services offering for health systems that is designed to help fuel more efficient and sustainable RPM workflows that can lead to improved patient and care delivery team experiences.
  • RICOH RPM Enablement comes at a time when health systems are grappling with a simultaneous monumental shift to virtual care delivery and an unprecedented shortage of healthcare workers.
  • RICOH RPM Enablement is designed to help health systems close this gap and to help lead to improved patient experiences by integrating into existing virtual care programs to support the deployment of remote patient monitoring system devices, inventory tracking, logistics, and device returns.
  • Additional details about RICOH Remote Patient Monitoring Enablement can be found here: https://www.ricoh-usa.com/en/industries/healthcare/rpm-enablement .

Trinity Biotech Announces Q2 2023 Financial Results

Retrieved on: 
Tuesday, October 3, 2023

DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2023.

Key Points: 
  • DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2023.
  • Total revenue for fiscal Q2, 2023 was $13.9m (excluding Fitzgerald Industries, which was disposed of in April 2023).
  • In August, Trinity Biotech received U.S. FDA 510(k) clearance for the Premier Resolution System, the automated analyzer for accurate & precise quantification of haemoglobin variants.
  • Total revenues for Q2, 2023 were $13.9m which compares to $15.4m in Q2, 2022, a decrease of 9.8% and which were broken down as follows:

Enovix Announces Strategic Realignment of Fab1 to Improve Operational Efficiency and Enhance Technology Development

Retrieved on: 
Tuesday, October 3, 2023

This move is supportive of the Company’s strategy to locate high-volume manufacturing in Asia near customers and suppliers while locating technology development in both Silicon Valley and Asia.

Key Points: 
  • This move is supportive of the Company’s strategy to locate high-volume manufacturing in Asia near customers and suppliers while locating technology development in both Silicon Valley and Asia.
  • Enovix expects this restructuring to be completed during the fourth quarter of 2023 and result in annualized savings of approximately $22 million.
  • In 2024, Fab1 will shift to housing the R&D Agility Line and will be used for new technology development, materials research, process engineering, and customer sampling.
  • Enovix also plans to add dry room space at Fab1 for battery prototyping work to support engagements with Automotive OEMs.

Mayo Clinic to deploy and test Microsoft generative AI tools

Retrieved on: 
Thursday, September 28, 2023

Mayo Clinic is testing the Microsoft 365 Copilot Early Access Program with hundreds of its clinical staff, doctors and healthcare workers.

Key Points: 
  • Mayo Clinic is testing the Microsoft 365 Copilot Early Access Program with hundreds of its clinical staff, doctors and healthcare workers.
  • Mayo Clinic is one of the first to start working with Copilot tools to enable staff experience across apps like Microsoft Outlook, Word, Excel and more.
  • "Privacy, ethics and safety are at the forefront of Mayo Clinic's work with generative AI and large language models," said Cris Ross, chief information officer at Mayo Clinic.
  • By using generative AI and LLMs, Mayo Clinic will be able to offer its teams new timesaving tools to help them succeed.

Texas Vein and Wellness Institute Achieves Accreditation for Peripheral Arterial Intervention & Deep Venous from Intersocietal Accreditation Commission

Retrieved on: 
Tuesday, September 26, 2023

HOUSTON, Sept. 25, 2023 /PRNewswire/ -- Texas Vein & Wellness Institute (TXVWI), a leading provider of vein and vascular care in the Houston area, is proud to announce its recent accreditation for Peripheral Arterial Interventions and Deep Venous by the Intersocietal Accreditation Commission (IAC). TXVWI is the only facility in Houston to have achieved this prestigious accreditation, underscoring TXVWI's commitment to maintaining the highest standards of patient care, safety and excellence.

Key Points: 
  • HOUSTON, Sept. 25, 2023 /PRNewswire/ -- Texas Vein & Wellness Institute (TXVWI), a leading provider of vein and vascular care in the Houston area, is proud to announce its recent accreditation for Peripheral Arterial Interventions and Deep Venous by the Intersocietal Accreditation Commission (IAC).
  • The IAC Accreditations for Peripheral Arterial Interventions and Deep Venous are recognized as the benchmark for facilities in the field of vein and vascular care.
  • Dr. Rao emphasized the significance of this accreditation for both the institute and its patients:
    "IAC accreditation is a vital milestone for TXVWI as we continue to progress in the vein and vascular space.
  • Texas Vein & Wellness Institute is a premier vein and vascular center founded in 2013.

Orion Innovation Names Mark Berler EVP of Growth to Accelerate Strategic Initiatives and Expansion Plans

Retrieved on: 
Thursday, September 21, 2023

EDISON, N.J., Sept. 21, 2023 /PRNewswire/ -- Orion Innovation ("Orion"), a leading digital transformation and product development services firm, has named Mark Berler as its Executive Vice President of Growth.

Key Points: 
  • EDISON, N.J., Sept. 21, 2023 /PRNewswire/ -- Orion Innovation ("Orion"), a leading digital transformation and product development services firm, has named Mark Berler as its Executive Vice President of Growth.
  • He will provide leadership across all growth efforts, including building new client relationships, supporting large pursuits, and creating indirect channels for partnerships and alliances.
  • "Orion has built an extraordinary, new global IT services model that delivers transformative business solutions with agility at scale," said Berler.
  • "As a trusted partner who inspires and accelerates digital innovation, Orion is a catalyst to help clients achieve their growth initiatives.

LG AND CLEARBROOK ANNOUNCE STRATEGIC INVESTMENT FUND TO ACCELERATE GLOBAL INNOVATION

Retrieved on: 
Thursday, August 3, 2023

SANTA CLARA, Calif., Aug. 2, 2023 /PRNewswire/ -- Global innovator LG Electronics and Clearbrook LLC, a global investment advisory and asset management firm with nearly two decades of experience in impact and sustainable investing, announced a strategic alliance to support companies developing solutions to bring positive change to people and the planet. The two companies are collaborating in NOVA Prime Fund, a venture capital fund with a target of more than $100 million (USD). The Fund's objective will be to invest in companies advancing innovations to build a better future, drawing from the pool of companies participating in the Mission for the Future Program sponsored by LG Electronics' North America Center for Innovation, LG NOVA.

Key Points: 
  • The two companies are collaborating in NOVA Prime Fund, a venture capital fund with a target of more than $100 million (USD).
  • "As a part of our business transformation to a Smart Life Solution company, LG is innovating to expand its services and solutions in new areas of business growth," said LG Electronics Global CEO William Cho.
  • Clearbrook's investment track record with a clear focus on impact and sustainable investing aligns perfectly with LG NOVA's mission."
  • "By investing in this fund, we are intentionally bridging sustainability and innovation to drive exponential growth in viable solutions for the challenges we face today," said Sokwoo Rhee, Head of LG NOVA and SVP of Innovation for LG Electronics.

NeuroFlow Acquires Parent Company of BHL and BHL Touch to Expand and Support the Delivery of Integrated Behavioral Health Throughout the VA and Other Healthcare Partners

Retrieved on: 
Tuesday, July 18, 2023

PHILADELPHIA, July 18, 2023 /PRNewswire-PRWeb/ -- NeuroFlow, the leading provider of behavioral health technology infrastructure, today announced that it has acquired Capital Solution Design (CSD), parent company to Behavioral Health Lab (BHL) and BHL Touch, a leading provider of measurement-based care solutions for the U.S. Department of Veterans Affairs (VA) and other healthcare organizations. The acquisition makes CSD a wholly-owned subsidiary, bringing BHL and BHL Touch and the company's talent to NeuroFlow, reinforcing NeuroFlow's best-in-class position as a technology enabler and infrastructure powering integrated behavioral healthcare at scale.

Key Points: 
  • The acquisition makes CSD a wholly-owned subsidiary, bringing BHL and BHL Touch and the company's talent to NeuroFlow, reinforcing NeuroFlow's best-in-class position as a technology enabler and infrastructure powering integrated behavioral healthcare at scale.
  • "BHL has an impressive reputation with their existing partners for enabling measurement-based care.
  • "We are eager to accelerate the implementation of BHL and BHL Touch at new facilities within the VA and to continue with various exciting collaborations and product developments already in progress."
  • With more than 150 public and private healthcare facilities as partners, BHL has collected over one million assessments in the last year alone.